AdvaMed: Administration Plan to Purchase 500 Million Covid Tests an “Encouraging Next Step,” Says More Must Be Done
WASHINGTON, D.C. – Today, the Advanced Medical Technology Association (AdvaMed) released the following statement from President and CEO Scott Whitaker regarding the White House’s newest measures to address the COVID-19 pandemic and rising cases related to the Omicron variant:
“A consistent, reliable supply of rapid Covid tests is critical to getting our country through to the other side of this pandemic. The Administration’s announcement today that it will purchase 500 million COVID tests is an encouraging next step, and this guaranteed-purchase approach is one of several we have urged this Administration to take.
“Market predictability has been absolutely imperative for the diagnostic testing industry throughout this pandemic, particularly given its unique and vital role in patient care. The federal government can and should play the pivotal role of guaranteeing the market for these Covid tests going forward, so that our testing supply remains where it needs to be and diagnostics companies know how best to meet demand.
“We have learned throughout this pandemic that Covid is highly unpredictable and more variants are on their way. We look forward to working with the Administration on strengthening federal policy so that it reflects Covid’s unpredictability and allows our companies to continue the incredible lifesaving work they’ve done since the beginning of this pandemic.”
# # #
AdvaMed member companies produce the medical devices, diagnostic products and digital health technologies that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.